NCT01870531

Brief Summary

This study is to determine the clinical and neuroimaging characteristics of Transient Ischemic Attacks in Korean populations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2010

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 23, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 6, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

June 9, 2015

Status Verified

June 1, 2015

Enrollment Period

2.7 years

First QC Date

May 23, 2013

Last Update Submit

June 6, 2015

Conditions

Transient Ischemic Attack

Keywords

Transient Ischemic Attack

Outcome Measures

Primary Outcomes (1)

  • Vascular events including ischemic strokes, myocardial infarctions, cardiovascular deaths

    90 days

Secondary Outcomes (1)

  • Recurrent transient ischemic attacks

    90 days

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

University Hospitals

You may qualify if:

  • Clinical symptoms and signs consistent with transient ischemic attack
  • Subject who admitted hospital within 24 hours after symptom onset
  • Subjects who underwent MRI (including diffusion-weighted images) and MRA (or CT angiography)

You may not qualify if:

  • Transient neurological symptoms due to
  • Migraine aura
  • Basilar migraine
  • Seizures
  • Syncope
  • Peripheral vertigo
  • Transient global amnesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Boramae Hospital

Seoul, Seoul, 156-707, South Korea

Location

MeSH Terms

Conditions

Ischemic Attack, Transient

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Yong-Seok Lee, MD, PhD

    Seoul National University Boramae Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
90 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 23, 2013

First Posted

June 6, 2013

Study Start

July 1, 2010

Primary Completion

March 1, 2013

Study Completion

August 1, 2013

Last Updated

June 9, 2015

Record last verified: 2015-06

Locations

KR(1)